semaglutide and optic neuritis Anterior nerve neuropathy – are they related? – GP Voice Eye Condition a 'Very Rare'

Switching rates were highest in January 2023 (around 3% for the study population regardless of the presence of type 2 diabetes (T2D) or overweight/obesity)

[1] It is administered as a once-weekly subcutaneous injection and belongs to a novel class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists

Working with Dr

Another valuable benefit of GLP-1 is its ability to slow down gastric emptyingthe process of food passing from your stomach into your small intestine

Right formulation, right indication, right patient

That is the molecule used in Ozempic for type 2 diabetes and Wegovy for obesity